Mycophenolic acid
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Antibiotics |
Catalog number | BBF-02567 |
CAS | 24280-93-1 |
Molecular Weight | 320.34 |
Molecular Formula | C17H20O6 |
Purity | >98% |
Online Inquiry
Description
Mycophenolic acid is a small lactone antibiotic produced by Pen. brevicom pactum and Pen. stoloniferum. Activity against gram-positive bacteria. In animal experiments, it has inhibitory effect on sarcoma-180, Lewis lung cancer, adenocarcinoma Ca-755, Walker tumor 256, Yoshida sarcoma, Freund ascites tumor, etc. Mycophenolic acid is a potent IMPDH inhibitor and the active metabolite of an immunosuppressive drug, used to prevent rejection in organ transplantation. It inhibits an enzyme needed for the growth of T cells and B cells.
Specification
Synonyms | Mycophenolate; Myfortic; Melbex |
Storage | -20°C |
IUPAC Name | (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid |
Canonical SMILES | CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O |
InChI | InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+ |
InChI Key | HPNSFSBZBAHARI-RUDMXATFSA-N |
Source | Penicillium sp. |
Properties
Appearance | Colorless Needle Crystal |
Application | Antibiotics, Antineoplastic |
Antibiotic Activity Spectrum | Gram-positive bacteria; neoplastics (Tumor) |
Boiling Point | 611.6°C at 760 mmHg |
Melting Point | 141°C |
Density | 1.29 g/cm3 |
Solubility | Soluble in ethanol, methanol, DMF or DMSO. Limited water solubility. |
LogP | 2.8 |
Toxicity
Carcinogenicity | No indication of carcinogenicity to humans (not listed by IARC). |
Mechanism Of Toxicity | Mycophenolic acid is a potent, selective, uncompetitive, and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. Because T- and B-lymphocytes are critically dependent for their proliferation on de novo synthesis of purines, whereas other cell types can utilize salvage pathways, mycophenolic acid has potent cytostatic effects on lymphocytes. Mycophenolic acid inhibits proliferative responses of T- and B-lymphocytes to both mitogenic and allospecific stimulation. Addition of guanosine or deoxyguanosine reverses the cytostatic effects of mycophenolic acid on lymphocytes. Mycophenolic acid also suppresses antibody formation by B-lymphocytes. Mycophenolic acid prevents the glycosylation of lymphocyte and monocyte glycoproteins that are involved in intercellular adhesion to endothelial cells and may inhibit recruitment of leukocytes into sites of inflammation and graft rejection. |
Toxicity | LD50: 352 mg/kg (Oral, Rat); LD50: 1000 mg/kg (Oral, Mouse); LD50: >6000 mg/kg (Oral, Rabbit). |
Reference Reading
Spectrum
Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive
Experimental Conditions
Ionization Energy: 70 eV
Chromatography Type: Gas Chromatography Column (GC)
Instrument Type: Single quadrupole, spectrum predicted by CFM-ID(EI)
Mass Resolution: 0.0001 Da
Molecular Formula: C17H20O6
Molecular Weight (Monoisotopic Mass): 320.126 Da
Molecular Weight (Avergae Mass): 320.3371 Da
LC-MS/MS Spectrum - LC-ESI-ITFT , negative
Experimental Conditions
Ionization Mode: negative
Recommended Products
BBF-01826 | Deoxymannojirimycin | Inquiry |
BBF-02642 | Lactonamycin | Inquiry |
BBF-03753 | Baicalin | Inquiry |
BBF-00677 | 3-Amino-3-deoxy-D-glucose | Inquiry |
BBF-03755 | Actinomycin D | Inquiry |
BBF-01825 | Loganin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2